Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 348

1.

Cisplatin and 5-fluorouracil with or without epidermal growth factor receptor inhibition panitumumab for patients with non-resectable, advanced or metastatic oesophageal squamous cell cancer: a prospective, open-label, randomised phase III AIO/EORTC trial (POWER).

Moehler M, Maderer A, Thuss-Patience PC, Brenner B, Meiler J, Ettrich TJ, Hofheinz RD, Al-Batran SE, Vogel A, Mueller L, Lutz MP, Lordick F, Alsina M, Borchert K, Greil R, Eisterer W, Schad A, Slotta-Huspenina J, Van Cutsem E, Lorenzen S.

Ann Oncol. 2020 Feb;31(2):228-235. doi: 10.1016/j.annonc.2019.10.018. Epub 2019 Dec 16.

PMID:
31959339
2.

Enquiring beneath the surface: can a gene expression assay shed light into the heterogeneity among newborns with neonatal encephalopathy?

Balada R, Tebé C, León M, Arca G, Alsina M, Castells AA, Alcántara S, Garcia-Alix A.

Pediatr Res. 2020 Jan 17. doi: 10.1038/s41390-020-0764-2. [Epub ahead of print]

PMID:
31952072
3.

Capturing Hyperprogressive disease with immune checkpoint inhibitors using RECIST 1.1 criteria.

Matos I, Martin-Liberal J, Garcia-Ruiz A, Hierro C, Ochoa de Olza M, Viaplana C, Azaro A, Vieito M, Brana I, Mur G, Ros J, Mateos J, Villacampa G, Berché R, Oliveira M, Alsina M, Élez E, Oaknin A, Muñoz-Couselo E, Carles J, Felip E, Rodon J, Tabernero J, Dienstmann R, Perez-Lopez R, Garralda E.

Clin Cancer Res. 2019 Nov 22. pii: clincanres.2226.2019. doi: 10.1158/1078-0432.CCR-19-2226. [Epub ahead of print]

PMID:
31757877
4.

Extension of the European Medicines Agency (EMA) approval of trifluridine/tipiracil for gastric cancer.

Alsina M, Smyth EC.

ESMO Open. 2019 Oct 1;4(5):e000591. doi: 10.1136/esmoopen-2019-000591. eCollection 2019. No abstract available.

5.

Efficacy and Safety of Trifluridine/Tipiracil Treatment in Patients With Metastatic Gastric Cancer Who Had Undergone Gastrectomy: Subgroup Analyses of a Randomized Clinical Trial.

Ilson DH, Tabernero J, Prokharau A, Arkenau HT, Ghidini M, Fujitani K, Van Cutsem E, Thuss-Patience P, Beretta GD, Mansoor W, Zhavrid E, Alsina M, George B, Catenacci D, McGuigan S, Makris L, Doi T, Shitara K.

JAMA Oncol. 2019 Oct 10. doi: 10.1001/jamaoncol.2019.3531. [Epub ahead of print]

6.

Estimation of surface thermal emissivity in a vineyard for UAV microbolometer thermal cameras using NASA HyTES hyperspectral thermal, Landsat and AggieAir optical data.

Torres-Rua A, Aboutalebi M, Wright T, Nassar A, Guillevic P, Hipps L, Gao F, Jim K, Alsina MM, Coopmans C, McKee M, Kustas W.

Proc SPIE Int Soc Opt Eng. 2019;11008. doi: 10.1117/12.2518958. Epub 2019 May 14.

PMID:
31359903
7.

How I treat gastric adenocarcinoma.

Alsina M, Miquel JM, Diez M, Castro S, Tabernero J.

ESMO Open. 2019 Jul 5;4(Suppl 2):e000521. doi: 10.1136/esmoopen-2019-000521. eCollection 2019. Review.

8.

The risk of urinary tract infections in patients with psoriasis on systemic medications in Biobadaderm Registry: A prospective cohort study.

Sahuquillo-Torralba A, Carretero G, Rivera R, Ferrándiz C, Daudén-Tello E, de la Cueva P, Gómez-García FJ, Belinchón I, Herrera-Acosta E, Ruiz-Genao D, Ferrán M, Alsina M, Sánchez-Carazo JL, Baniandrés O, Fernández-Freire LR, Vilar J, García-Donoso C, Carrascosa JM, Llamas-Velasco M, Herrera-Ceballos E, López-Estebaranz JL, Pujol-Marco C, Descalzo MÁ, García-Doval I; Biobadaderm Study Group.

J Am Acad Dermatol. 2019 Jul 13. pii: S0190-9622(19)32388-6. doi: 10.1016/j.jaad.2019.07.028. [Epub ahead of print] No abstract available.

PMID:
31306726
9.

Organic Nanotube with Subnanometer, pH-Responsive Lumen.

Darnall SM, Li C, Dunbar M, Alsina M, Keten S, Helms BA, Xu T.

J Am Chem Soc. 2019 Jul 17;141(28):10953-10957. doi: 10.1021/jacs.9b03732. Epub 2019 Jul 2.

PMID:
31265261
10.

Pharmacokinetic and exposure-response analysis of pertuzumab in patients with HER2-positive metastatic gastric or gastroesophageal junction cancer.

Kirschbrown WP, Wang B, Nijem I, Ohtsu A, Hoff PM, Shah MA, Shen L, Kang YK, Alsina M, Girish S, Garg A.

Cancer Chemother Pharmacol. 2019 Sep;84(3):539-550. doi: 10.1007/s00280-019-03871-w. Epub 2019 Jun 10.

11.

Women with moderate-to-severe psoriasis in Spain (BIOBADADERM registry) show more than a 50% reduction in age-adjusted fertility rate when compared with the general population.

Gonzalez-Cantero A, Carretero G, Rivera R, Ferrándiz C, Daudén E, de la Cueva P, Gómez-García FJ, Belinchón I, Herrera-Ceballos E, Ruiz-Genao D, Ferrán M, Alsina M, Sánchez-Carazo JL, Baniandrés O, Sahuquillo-Torralba A, Rodriguez L, Vilar J, García C, Carrascosa JM, Llamas-Velasco M, Herrera-Acosta E, López-Estebaranz JL, Botella-Estrada R, Descalzo MA, García-Doval I; BIOBADADERM Study Group.

Br J Dermatol. 2019 Nov;181(5):1085-1087. doi: 10.1111/bjd.18164. Epub 2019 Aug 13. No abstract available.

PMID:
31127858
12.

Sexually transmitted infections in young people and factors associated with HIV coinfection: an observational study in a large city.

Sentís A, Martin-Sanchez M, Arando M, Vall M, Barbera MJ, Ocaña I, González Cordón A, Alsina M, Martin-Ezquerra G, Knobel H, Gurguí M, Vives A, Coll J, Caylà JA, Garcia de Olalla P; STI-HIV group of Barcelona.

BMJ Open. 2019 May 5;9(5):e027245. doi: 10.1136/bmjopen-2018-027245.

13.

Weekly carfilzomib, lenalidomide, and dexamethasone in relapsed or refractory multiple myeloma: A phase 1b study.

Biran N, Siegel D, Berdeja JG, Raje N, Cornell RF, Alsina M, Kovacsovics T, Fang B, Kimball AS, Landgren O.

Am J Hematol. 2019 Jul;94(7):794-802. doi: 10.1002/ajh.25498. Epub 2019 May 13.

14.

Effectiveness and safety of ustekinumab 90 mg in patients weighing 100 kg or less: a retrospective, observational, multicenter study.

Del Alcázar E, Ferran M, López-Ferrer A, Notario J, Vidal D, Riera J, Aparicio G, Gallardo F, Vilarrasa E, Alsina M, Puig L, Ferrándiz C, Carrascosa JM.

J Dermatolog Treat. 2019 Mar 18:1-5. doi: 10.1080/09546634.2019.1597245. [Epub ahead of print]

PMID:
30883242
15.

Solving the problem with stannous fluoride: Formulation, stabilization, and antimicrobial action.

Myers CP, Pappas I, Makwana E, Begum-Gafur R, Utgikar N, Alsina MA, Fitzgerald M, Trivedi HM, Gaillard JF, Masters JG, Sullivan RJ.

J Am Dent Assoc. 2019 Apr;150(4S):S5-S13. doi: 10.1016/j.adaj.2019.01.004.

PMID:
30797260
16.

Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised, placebo-controlled, phase 3 trial.

Fuchs CS, Shitara K, Di Bartolomeo M, Lonardi S, Al-Batran SE, Van Cutsem E, Ilson DH, Alsina M, Chau I, Lacy J, Ducreux M, Mendez GA, Alavez AM, Takahari D, Mansoor W, Enzinger PC, Gorbounova V, Wainberg ZA, Hegewisch-Becker S, Ferry D, Lin J, Carlesi R, Das M, Shah MA; RAINFALL Study Group.

Lancet Oncol. 2019 Mar;20(3):420-435. doi: 10.1016/S1470-2045(18)30791-5. Epub 2019 Feb 1. Erratum in: Lancet Oncol. 2019 May;20(5):e242.

PMID:
30718072
17.

Lenalidomide-based response-adapted therapy for older adults without high risk myeloma.

Baz R, Naqvi SMH, Lee JH, Brayer J, Hillgruber N, Fridley BL, Shain KH, Sullivan DM, Alsina M.

Br J Haematol. 2019 Mar;184(5):735-743. doi: 10.1111/bjh.15700. Epub 2018 Dec 12.

PMID:
30548250
18.

Guidelines for Diagnosis and Treatment of Cutaneous Sarcomas: Dermatofibrosarcoma Protuberans.

Llombart B, Serra C, Requena C, Alsina M, Morgado-Carrasco D, Través V, Sanmartín O.

Actas Dermosifiliogr. 2018 Dec;109(10):868-877. doi: 10.1016/j.ad.2018.05.006. Epub 2018 Jul 4. Review. English, Spanish.

PMID:
30539729
19.

Histologic evidence that mast cells contribute to local tissue inflammation in peripheral spondyloarthritis by regulating interleukin-17A content.

Chen S, Noordenbos T, Blijdorp I, van Mens L, Ambarus CA, Vogels E, Te Velde A, Alsina M, Cañete JD, Yeremenko N, Baeten D.

Rheumatology (Oxford). 2019 Apr 1;58(4):617-627. doi: 10.1093/rheumatology/key331.

PMID:
30517745
20.

Leiomyosarcoma and Pleomorphic Dermal Sarcoma: Guidelines for Diagnosis and Treatment.

Llombart B, Serra-Guillén C, Requena C, Alsina M, Morgado-Carrasco D, Machado I, Sanmartín O.

Actas Dermosifiliogr. 2019 Jan - Feb;110(1):4-11. doi: 10.1016/j.ad.2018.06.012. Epub 2018 Nov 5. Review. English, Spanish.

PMID:
30409380
21.

Effects of resuspension on the mobility and chemical speciation of zinc in contaminated sediments.

Xie M, Alsina MA, Yuen J, Packman AI, Gaillard JF.

J Hazard Mater. 2019 Feb 15;364:300-308. doi: 10.1016/j.jhazmat.2018.10.043. Epub 2018 Oct 16.

PMID:
30384239
22.

Trifluridine/tipiracil versus placebo in patients with heavily pretreated metastatic gastric cancer (TAGS): a randomised, double-blind, placebo-controlled, phase 3 trial.

Shitara K, Doi T, Dvorkin M, Mansoor W, Arkenau HT, Prokharau A, Alsina M, Ghidini M, Faustino C, Gorbunova V, Zhavrid E, Nishikawa K, Hosokawa A, Yalçın Ş, Fujitani K, Beretta GD, Cutsem EV, Winkler RE, Makris L, Ilson DH, Tabernero J.

Lancet Oncol. 2018 Nov;19(11):1437-1448. doi: 10.1016/S1470-2045(18)30739-3. Epub 2018 Oct 21. Erratum in: Lancet Oncol. 2018 Dec;19(12):e668.

PMID:
30355453
23.

Kaposi Sarcoma and Cutaneous Angiosarcoma: Guidelines for Diagnosis and Treatment.

Requena C, Alsina M, Morgado-Carrasco D, Cruz J, Sanmartín O, Serra-Guillén C, Llombart B.

Actas Dermosifiliogr. 2018 Dec;109(10):878-887. doi: 10.1016/j.ad.2018.06.013. Epub 2018 Sep 24. Review. English, Spanish.

PMID:
30262126
24.

Treatment of patients with plaque psoriasis with secukinumab in a real-life setting: a 52-week, multicenter, retrospective study in Spain.

Notario J, Deza G, Vilarrasa E, Valentí F, Muñoz C, Mollet J, Rocamora V, Carrascosa JM, Del Alcázar E, Alsina M, Vidal D, Puig L, López-Ferrer A, Riera J, Gallardo F, Ferran M.

J Dermatolog Treat. 2019 Aug;30(5):424-429. doi: 10.1080/09546634.2018.1528000. Epub 2018 Dec 3.

PMID:
30244618
25.

Importance of the treatment of rectal Mycoplasma genitalium in men who have sex with men.

Riera-Monroig J, Fuertes I, Alsina M, Blanco JL.

Enferm Infecc Microbiol Clin. 2019 Oct;37(8):544-545. doi: 10.1016/j.eimc.2018.07.003. Epub 2018 Aug 30. English, Spanish. No abstract available.

PMID:
30173932
26.

Phase III, randomised trial of avelumab versus physician's choice of chemotherapy as third-line treatment of patients with advanced gastric or gastro-oesophageal junction cancer: primary analysis of JAVELIN Gastric 300.

Bang YJ, Ruiz EY, Van Cutsem E, Lee KW, Wyrwicz L, Schenker M, Alsina M, Ryu MH, Chung HC, Evesque L, Al-Batran SE, Park SH, Lichinitser M, Boku N, Moehler MH, Hong J, Xiong H, Hallwachs R, Conti I, Taieb J.

Ann Oncol. 2018 Oct 1;29(10):2052-2060. doi: 10.1093/annonc/mdy264.

27.

Gay Circuit Parties in Barcelona and Their Impact on Gonorrhea Incidence.

Leyva-Moral JM, Feijoo-Cid M, Moriña D, Caylà JA, Arando M, Vall M, Barbera MJ, Armengol P, Vives A, Martin-Ezquerra G, Alsina M, García Olalla P.

Arch Sex Behav. 2018 Oct;47(7):2027-2034. doi: 10.1007/s10508-018-1220-9. Epub 2018 Jul 16.

PMID:
30014338
28.

Pancreatic panniculitis: A case series from a tertiary university hospital in Spain.

Fernández-Sartorio C, Combalia A, Ferrando J, Alsina M, Iranzo P, Estrach T, Hernández-Ruiz E, Mascaró JM Jr.

Australas J Dermatol. 2018 Nov;59(4):e269-e272. doi: 10.1111/ajd.12842. Epub 2018 May 9.

PMID:
29741276
29.

Laboratory sample stability. Is it possible to define a consensus stability function? An example of five blood magnitudes.

Gómez Rioja R, Martínez Espartosa D, Segovia M, Ibarz M, Llopis MA, Bauça JM, Marzana I, Barba N, Ventura M, García Del Pino I, Puente JJ, Caballero A, Gómez C, García Álvarez A, Alsina MJ, Álvarez V.

Clin Chem Lab Med. 2018 Oct 25;56(11):1806-1818. doi: 10.1515/cclm-2017-1189. Review.

30.

Immunotherapy of Esophageal Cancer: Current Status, Many Trials and Innovative Strategies.

Alsina M, Moehler M, Lorenzen S.

Oncol Res Treat. 2018;41(5):266-271. doi: 10.1159/000488120. Epub 2018 Apr 20. Review.

31.

Genomic Profiling of HER2-Positive Gastric Cancer: PI3K/Akt/mTOR Pathway as Predictor of Outcomes in HER2-Positive Advanced Gastric Cancer Treated with Trastuzumab.

Díaz-Serrano A, Angulo B, Dominguez C, Pazo-Cid R, Salud A, Jiménez-Fonseca P, Leon A, Galan MC, Alsina M, Rivera F, Plaza JC, Paz-Ares L, Lopez-Rios F, Gómez-Martín C.

Oncologist. 2018 Sep;23(9):1092-1102. doi: 10.1634/theoncologist.2017-0379. Epub 2018 Apr 26.

32.

Structural characterization of metal complexes in aqueous solutions: a XAS study of stannous fluoride.

Alsina MA, Gaillard JF.

Phys Chem Chem Phys. 2018 May 9;20(18):12727-12735. doi: 10.1039/c8cp01461b.

PMID:
29697121
33.

ECCO essential requirements for quality cancer care: Oesophageal and gastric cancer.

Allum W, Lordick F, Alsina M, Andritsch E, Ba-Ssalamah A, Beishon M, Braga M, Caballero C, Carneiro F, Cassinello F, Dekker JW, Delgado-Bolton R, Haustermans K, Henning G, Hutter B, Lövey J, Netíková IŠ, Obermannová R, Oberst S, Rostoft S, Saarto T, Seufferlein T, Sheth S, Wynter-Blyth V, Costa A, Naredi P.

Crit Rev Oncol Hematol. 2018 Feb;122:179-193. doi: 10.1016/j.critrevonc.2017.12.019. Epub 2018 Jan 2. Review.

34.

Case Report of IgM Multiple Myeloma: Diagnosing a Rare Hematologic Entity.

Bonilla-Valentín FJ, Cerra J, Cáceres-Perkins W, Alsina M.

Cancer Control. 2018 Jan-Mar;25(1):1073274817744448. doi: 10.1177/1073274817744448.

35.

Targeting the fibroblast growth factor receptor 2 in gastric cancer: promise or pitfall?

Hierro C, Alsina M, Sánchez M, Serra V, Rodon J, Tabernero J.

Ann Oncol. 2018 Jul 1;29(7):1605. doi: 10.1093/annonc/mdx800. No abstract available.

36.

NCCN Guidelines Insights: Multiple Myeloma, Version 3.2018.

Kumar SK, Callander NS, Alsina M, Atanackovic D, Biermann JS, Castillo J, Chandler JC, Costello C, Faiman M, Fung HC, Godby K, Hofmeister C, Holmberg L, Holstein S, Huff CA, Kang Y, Kassim A, Liedtke M, Malek E, Martin T, Neppalli VT, Omel J, Raje N, Singhal S, Somlo G, Stockerl-Goldstein K, Weber D, Yahalom J, Kumar R, Shead DA.

J Natl Compr Canc Netw. 2018 Jan;16(1):11-20. doi: 10.6004/jnccn.2018.0002.

PMID:
29295877
37.

Correction to: A Phase II Study Evaluating Combined Neoadjuvant Cetuximab and Chemotherapy Followed by Chemoradiotherapy and Concomitant Cetuximab in Locoregional Oesophageal Cancer Patients.

Alsina M, Rivera F, Ramos FJ, Galán M, López R, García-Alfonso P, Alés-Martinez JE, Queralt B, Antón A, Carrato A, Grávalos C, Méndez-Vidal MJ, López C, de Mena IR, Tabernero J, Giralt J, Aranda E; Spanish Cooperative Group for the Treatment of Digestive Tumors (TTD) and Grupo de Investigación Clínica en Oncología Radioterápica (GICOR).

Target Oncol. 2018 Feb;13(1):79. doi: 10.1007/s11523-017-0544-z.

PMID:
29243205
38.

Genetic and experimental evidence for the involvement of the CD6 lymphocyte receptor in psoriasis.

Consuegra-Fernández M, Julià M, Martínez-Florensa M, Aranda F, Català C, Armiger-Borràs N, Arias MT, Santiago F, Guilabert A, Esteve A, Muñoz C, Ferrándiz C, Carrascosa JM, Pedrosa E, Romaní J, Alsina M, Mascaró-Galy JM, Lozano F.

Cell Mol Immunol. 2018 Oct;15(10):898-906. doi: 10.1038/cmi.2017.119. Epub 2017 Dec 11.

39.

Change over time in the rates of adverse events in patients receiving systemic therapy for psoriasis: A cohort study.

Descalzo MA, Carretero G, Ferrándiz C, Rivera R, Daudén E, Gómez-García FJ, de la Cueva P, Herrera-Ceballos E, Belinchón I, López-Estebaranz JL, Alsina M, Sánchez-Carazo JL, Ferrán M, Baniandrés O, Carrascosa JM, Llamas-Velasco M, Ruiz-Genao D, Herrera-Acosta E, Muñoz-Santos C, García-Doval I; Biobadaderm Study Group.

J Am Acad Dermatol. 2018 Apr;78(4):798-800. doi: 10.1016/j.jaad.2017.10.051. Epub 2017 Nov 13. No abstract available.

PMID:
29146129
40.

A phase II Study Evaluating Combined Neoadjuvant Cetuximab and Chemotherapy Followed by Chemoradiotherapy and Concomitant Cetuximab in Locoregional Oesophageal Cancer Patients.

Alsina M, Rivera F, Ramos FJ, Galán M, López R, García-Alfonso P, Alés-Martinez JE, Queralt B, Antón A, Carrato A, Grávalos C, Méndez-Vidal MJ, López C, de Mena IR, Tabernero J, Giralt J, Aranda E; Spanish Cooperative Group for the Treatment of Digestive Tumors (TTD) and Grupo de Investigación Clínica en Oncología Radioterápica (GICOR).

Target Oncol. 2018 Feb;13(1):69-78. doi: 10.1007/s11523-017-0536-z. Erratum in: Target Oncol. 2017 Dec 14;:.

PMID:
29128908
41.

A Multi-Arm Phase I Study of the PI3K/mTOR Inhibitors PF-04691502 and Gedatolisib (PF-05212384) plus Irinotecan or the MEK Inhibitor PD-0325901 in Advanced Cancer.

Wainberg ZA, Alsina M, Soares HP, Braña I, Britten CD, Del Conte G, Ezeh P, Houk B, Kern KA, Leong S, Pathan N, Pierce KJ, Siu LL, Vermette J, Tabernero J.

Target Oncol. 2017 Dec;12(6):775-785. doi: 10.1007/s11523-017-0530-5.

42.

Recurrent cardiotoxicity potentiated by the interaction of proteasome inhibitor and immunomodulatory therapy for the treatment of multiple myeloma.

Fradley MG, Groarke JD, Laubach J, Alsina M, Lenihan DJ, Cornell RF, Maglio M, Shain KH, Richardson PG, Moslehi J.

Br J Haematol. 2018 Jan;180(2):271-275. doi: 10.1111/bjh.14970. Epub 2017 Oct 19.

PMID:
29048105
43.

Hypoalbuminemia at Day +90 Is Associated with Inferior Nonrelapse Mortality and Overall Survival in Allogeneic Hematopoietic Cell Transplantation Recipients: A Confirmatory Study.

Murthy HS, Sheets K, Kumar A, Nishihori T, Mina A, Chavez JC, Ayala E, Field T, Mathews J, Locke F, Perez L, Betts BC, Khimani F, Miladinovic B, Tsalatsanis A, Ochoa-Bayona JL, Alsina M, Fernandez H, Pidala J, Anasetti C, Kharfan-Dabaja MA.

Biol Blood Marrow Transplant. 2018 Feb;24(2):400-405. doi: 10.1016/j.bbmt.2017.09.022. Epub 2017 Oct 13.

44.

A phase III trial comparing oral S-1/cisplatin and intravenous 5-fluorouracil/cisplatin in patients with untreated diffuse gastric cancer.

Ajani JA, Abramov M, Bondarenko I, Shparyk Y, Gorbunova V, Hontsa A, Otchenash N, Alsina M, Lazarev S, Feliu J, Elme A, Esko V, Abdalla K, Verma U, Benedetti F, Aoyama T, Mizuguchi H, Makris L, Rosati G; DIGEST Study Group.

Ann Oncol. 2017 Sep 1;28(9):2142-2148. doi: 10.1093/annonc/mdx275.

PMID:
28911091
45.

A phase I open-label dose-escalation study of the anti-HER3 monoclonal antibody LJM716 in patients with advanced squamous cell carcinoma of the esophagus or head and neck and HER2-overexpressing breast or gastric cancer.

Reynolds KL, Bedard PL, Lee SH, Lin CC, Tabernero J, Alsina M, Cohen E, Baselga J, Blumenschein G Jr, Graham DM, Garrido-Laguna I, Juric D, Sharma S, Salgia R, Seroutou A, Tian X, Fernandez R, Morozov A, Sheng Q, Ramkumar T, Zubel A, Bang YJ.

BMC Cancer. 2017 Sep 12;17(1):646. doi: 10.1186/s12885-017-3641-6.

46.

Copper Corrosion and Biocorrosion Events in Premise Plumbing.

Vargas IT, Fischer DA, Alsina MA, Pavissich JP, Pastén PA, Pizarro GE.

Materials (Basel). 2017 Sep 5;10(9). pii: E1036. doi: 10.3390/ma10091036. Review.

47.

Efficacy of passive hypothermia and adverse events during transport of asphyxiated newborns according to the severity of hypoxic-ischemic encephalopathy.

Carreras N, Alsina M, Alarcon A, Arca-Díaz G, Agut T, García-Alix A.

J Pediatr (Rio J). 2018 May - Jun;94(3):251-257. doi: 10.1016/j.jped.2017.05.009. Epub 2017 Aug 18.

48.

Study of the interaction of GB virus C/Hepatitis G virus fusion peptides belonging to the E2 protein with phospholipid Langmuir monolayers.

Pérez-López S, Espina M, Gómara MJ, Fidalgo JL, Alsina MA, Mestres C, Miñones Conde J.

Colloids Surf B Biointerfaces. 2017 Oct 1;158:278-286. doi: 10.1016/j.colsurfb.2017.06.043. Epub 2017 Jun 28.

49.

Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: a multicenter IMWG study.

Kumar SK, Dimopoulos MA, Kastritis E, Terpos E, Nahi H, Goldschmidt H, Hillengass J, Leleu X, Beksac M, Alsina M, Oriol A, Cavo M, Ocio EM, Mateos MV, O'Donnell EK, Vij R, Lokhorst HM, van de Donk NWCJ, Min C, Mark T, Turesson I, Hansson M, Ludwig H, Jagannath S, Delforge M, Kyriakou C, Hari P, Mellqvist U, Usmani SZ, Dytfeld D, Badros AZ, Moreau P, Kim K, Otero PR, Lee JH, Shustik C, Waller D, Chng WJ, Ozaki S, Lee JJ, de la Rubia J, Eom HS, Rosinol L, Lahuerta JJ, Sureda A, Kim JS, Durie BGM.

Leukemia. 2017 Nov;31(11):2443-2448. doi: 10.1038/leu.2017.138. Epub 2017 May 12.

PMID:
28620163
50.

Analysis of mutant allele fractions in driver genes in colorectal cancer - biological and clinical insights.

Dienstmann R, Elez E, Argiles G, Matos I, Sanz-Garcia E, Ortiz C, Macarulla T, Capdevila J, Alsina M, Sauri T, Verdaguer H, Vilaro M, Ruiz-Pace F, Viaplana C, Garcia A, Landolfi S, Palmer HG, Nuciforo P, Rodon J, Vivancos A, Tabernero J.

Mol Oncol. 2017 Sep;11(9):1263-1272. doi: 10.1002/1878-0261.12099. Epub 2017 Jul 20.

Supplemental Content

Loading ...
Support Center